- Home
- UNCY vs PROV Comparison
UNCY vs PROV Comparison
Compare UNCY & PROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- PROV
- Stock Information
- Founded
- UNCY 2016
- PROV 1956
- Country
- UNCY United States
- PROV United States
- Employees
- UNCY N/A
- PROV N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- PROV Savings Institutions
- Sector
- UNCY Health Care
- PROV Finance
- Exchange
- UNCY Nasdaq
- PROV Nasdaq
- Market Cap
- UNCY 91.0M
- PROV 100.7M
- IPO Year
- UNCY 2021
- PROV 1996
- Fundamental
- Price
- UNCY $4.87
- PROV $15.49
- Analyst Decision
- UNCY Strong Buy
- PROV Hold
- Analyst Count
- UNCY 4
- PROV 1
- Target Price
- UNCY $63.75
- PROV $16.50
- AVG Volume (30 Days)
- UNCY 934.5K
- PROV 8.8K
- Earning Date
- UNCY 08-13-2025
- PROV 07-28-2025
- Dividend Yield
- UNCY N/A
- PROV 3.62%
- EPS Growth
- UNCY N/A
- PROV N/A
- EPS
- UNCY N/A
- PROV 0.97
- Revenue
- UNCY N/A
- PROV $39,909,000.00
- Revenue This Year
- UNCY N/A
- PROV $3.06
- Revenue Next Year
- UNCY $1,458.53
- PROV $9.15
- P/E Ratio
- UNCY N/A
- PROV $15.96
- Revenue Growth
- UNCY N/A
- PROV 1.24
- 52 Week Low
- UNCY $2.02
- PROV $12.72
- 52 Week High
- UNCY $11.00
- PROV $16.70
- Technical
- Relative Strength Index (RSI)
- UNCY 45.55
- PROV 47.68
- Support Level
- UNCY $4.38
- PROV $15.45
- Resistance Level
- UNCY $4.96
- PROV $15.81
- Average True Range (ATR)
- UNCY 0.31
- PROV 0.30
- MACD
- UNCY 0.05
- PROV -0.02
- Stochastic Oscillator
- UNCY 41.88
- PROV 40.48
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About PROV Provident Financial Holdings Inc.
Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. Through the bank, it is engaged in providing community and mortgage banking services to consumers and small to mid-sized businesses in the Inland Empire region of Southern California. The company's business segment is Bank. The Bank's activities include attracting deposits, offering banking services, and originating and purchasing single-family, multi-family, commercial real estate, construction, and other mortgage loans and, to a lesser extent, commercial business and consumer loans held for investment.